-
1Academic Journal
Συγγραφείς: A. F. Murtazina, P. N. Tsabay, G. E. Rudenskaya, L. A. Bessonova, F. M. Bostanova, D. M. Guseva, I. V. Sharkova, O. A. Shchagina, A. A. Orlova, O. P. Ryzhkova, T. V. Markova, A. S. Kuchina, S. S. Nikitin, E. L. Dadali, А. Ф. Муртазина, П. Н. Цабай, Г. Е. Руденская, Л. А. Бессонова, Ф. М. Бостанова, Д. М. Гусева, И. В. Шаркова, О. А. Щагина, А. А. Орлова, О. П. Рыжкова, Т. В. Маркова, А. С. Кучина, С. С. Никитин, Е. Л. Дадали
Πηγή: Neuromuscular Diseases; Том 13, № 2 (2023); 42-55 ; Нервно-мышечные болезни; Том 13, № 2 (2023); 42-55 ; 2413-0443 ; 2222-8721 ; 10.17650/2222-8721-2023-13-2
Θεματικοί όροι: TRPV4, Charcot–Marie–Tooth disease 2C, scapuloperoneal spinal muscular atrophy, congenital distal spinal muscular atrophy, болезнь Шарко–Мари–Тута 2С, скапуло‑перонеальная спинальная мышечная атрофия, врожденная дистальная спинальная мышечная атрофия
Περιγραφή αρχείου: application/pdf
Relation: https://nmb.abvpress.ru/jour/article/view/542/349; Auer-Grumbach M., Olschewski A., Papic L. et al. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet 2010;42(2): 160–4. DOI:10.1038/ng.508; Zimon M., Baets J., Auer-Grumbach M. et al. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain 2010;133(Pt 6):1798–809. DOI:10.1093/brain/awq109; Fiorillo C., Moro F., Brisca G. et al. TRPV4 mutations in children with congenital distal spinal muscular atrophy. Neurogenetics 2012;13(3):195–203. DOI:10.1007/s10048-012-0328-7; Chen D.H., Sul Y., Weiss M. et al. CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene. Neurology 2010;75(22):1968–75. DOI:10.1212/WNL.0b013e3181ffe4bb; Aharoni S., Harlalka G., Offiah A. et al. Striking phenotypic variability in familial TRPV4-axonal neuropathy spectrum disorder. Am J Med Genet A 2011;155A(12):3153–6. DOI:10.1002/ajmg.a.34327; Berciano J., Baets J., Gallardo E. et al. Reduced penetrance in hereditary motor neuropathy caused by TRPV4 Arg269Cys mutation. J Neurol 2011;258(8):1413–21. DOI:10.1007/s00415-011-5947-7; Koutsis G., Lynch D., Manole A. et al. Charco–Marie–Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation. J Neurol 2015;262(8):1972–5. DOI:10.1007/s00415-015-7800-x; Vill K., Kuhn M., Glaser D. et al. Long-term observations in an affected family with neurogenic scapuloperoneal syndrome caused by mutation R269C in the TRPV4 gene. Neuropediatrics 2015;46(4):282–6. DOI:10.1055/s-0035-1554100; Jedrzejowska M., Debek E., Kowalczyk B. et al. The remarkable phenotypic variability of the p.Arg269HiS variant in the TRPV4 gene. Muscle Nerve 2019;59(1):129–33. DOI:10.1002/mus.26346; Garcia-Elias A., Lorenzo I.M., Vicente R. et al. IP3 receptor binds to and sensitizes TRPV4 channel to osmotic stimuli viaa calmodulin-binding site. J Biol Chem 2008;283(46):31284–8. DOI:10.1074/jbc.C800184200; Kottgen M., Buchholz B., Garcia-Gonzalez M.A. et al. TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol 2008;182(3):437–47. DOI:10.1083/jcb.200805124; Donate-Macian P., Jungfleisch J., Perez-Vilaro G. et al. The TRPV4 channel links calcium influx to DDX3X activity and viral infectivity. Nat Commun 2018;9(1):2307. DOI:10.1038/s41467-018-04776-7; Arniges M., Fernandez-Fernandez J.M., Albrecht N. et al. Human TRPV4 channel splice variants revealed a key role of ankyrin domains in multimerization and trafficking. J Biol Chem 2006;281(3):1580–6. DOI:10.1074/jbc.M511456200; Takahashi N., Hamada-Nakahara S., Itoh Y. et al. TRPV4 channel activity is modulated by direct interaction of the ankyrin domain to PI(4,5)P(2). Nat Commun 2014;5:4994. DOI:10.1038/ncomms5994; Strotmann R., Schultz G., Plant T.D. Ca2+-dependent potentiation of the nonselective cation channel TRPV4 is mediated by a C-terminal calmodulin binding site. J Biol Chem 2003;278(29):26541–9. DOI:10.1074/jbc.M302590200; Stenson P.D., Ball E.V., Mort M. et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003;21(6):577–81. DOI:10.1002/humu.10212; Deng H.X., Klein C.J., Yan J. et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 2010;42(2):165–9. DOI:10.1038/ng.509; Landoure G., Zdebik A.A., Martinez T.L. et al. Mutations in TRPV4 cause Charcot–Marie–Tooth disease type 2C. Nat Genet 2010;42(2):170–4. DOI:10.1038/ng.512; Fecto F., Shi Y., Huda R. et al. Mutant TRPV4-mediated toxicity is linked to increased constitutive function in axonal neuropathies. J Biol Chem 2011;286(19):17281–91. DOI:10.1074/jbc.M111.237685; Klein C.J., Shi Y., Fecto F. et al. TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot–Marie–Tooth neuropathies. Neurology 2011;76(10):887–94. DOI:10.1212/WNL.0b013e31820f2de3; Sullivan J.M., Zimanyi C.M., Aisenberg W. et al. Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4-mediated neuropathy. Neurol Genet 2015;1(4):e29. DOI:10.1212/NXG.0000000000000029; Taga A., Peyton M.A., Goretzki B. et al. TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function. Ann Clin Transl Neurol 2022;9(3):375–91. DOI:10.1002/acn3.51523; Cho T.J., Matsumoto K., Fano V. et al. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients. Am J Med Genet A 2012;158A(4):795–802. DOI:10.1002/ajmg.a.35268; Fawcett K.A., Murphy S.M., Polke J.M. et al. Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls. J Neurol Neurosurg Psychiatry 2012;83(12):1204–9. DOI:10.1136/jnnp-2012-303055; Drew A.P., Zhu D., Kidambi A. et al. Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing. Mol Genet Genomic Med 2015;3(2):143–54. DOI:10.1002/mgg3.126; Uchoa Cavalcanti E.B., Santos S.C.L., Martins C.E.S. et al. Char-cot-Marie-Tooth disease: Genetic profile of patients from a large Brazilian neuromuscular reference center. J Peripher Nerv Syst 2021;26(3):290–7. DOI:10.1111/jns.12458; Volodarsky M., Kerkhof J., Stuart A. et al. Comprehensive genetic sequence and copy number analysis for Charcot–Marie–Tooth disease in a Canadian cohort of 2517 patients. J Med Genet 2021;58(4):284–8. DOI:10.1136/jmedgenet-2019-106641; Dai J., Kim O.H., Cho T.J. et al. Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family. J Med Genet 2010;47(10):704–9. DOI:10.1136/jmg.2009.075358; Маркова Т.В., Кенис В.М., Мельченко Е.В. и др. Клиникогенетические характеристики TRPV4-ассоциированных скелетных дисплазий у российских пациентов. Медицинская генетика 2022;21(4):25–37. DOI:10.25557/2073-7998.2022.04.25-37; Inada H., Procko E., Sotomayor M. et al. Structural and biochemical consequences of disease-causing mutations in the ankyrin repeat domain of the human TRPV4 channel. Biochemistry 2012;51(31):6195–206. DOI:10.1021/bi300279b; McCray B.A., Diehl E., Sullivan J.M. et al. Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension. Nat Commun 2021;12(1):1444. DOI:10.1038/s41467-021-21699-y; Dyck P.J., Litchy W.J., Minnerath S. et al. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 1994;35(5):608–15. DOI:10.1002/ana.410350515; Deng S., Feely S.M.E., Shi Y. et al. Incidence and clinical features of TRPV4-linked axonal neuropathies in a USA cohort of Char-cot–Marie–Tooth disease type 2. Neuromolecular Med 2020;22(1):68–72. DOI:10.1007/s12017-019-08564-4; Fleury P., Hageman G. A dominantly inherited lower motor neuron disorder presenting at birth with associated arthrogryposis. J Neurol Neurosurg Psychiatry 1985;48(10):1037–48. DOI:10.1136/jnnp.48.10.1037; Van der Vleuten A.J., van Ravenswaaij-Arts C.M., Frijns C.J. et al. Localisation of the gene for a dominant congenital spinal muscular atrophy predominantly affecting the lower limbs to chromosome 12q23–q24. Eur J Hum Genet 1998;6(4):376–82. DOI:10.1038/sj.ejhg.5200229; Echaniz-Laguna A., Dubourg O., Carlier P. et al. Phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathy. Neurology 2014;82(21):1919–26. DOI:10.1212/WNL.0000000000000450; Rossor A.M., Kalmar B., Greensmith L. et al. The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry 2012;83(1): 6–14. DOI:10.1136/jnnp-2011-300952; DeLong R., Siddique T. A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features. Arch Neurol 1992;49(9):905–8. DOI:10.1001/archneur.1992.00530330027010; McEntagart M. TRPV4 axonal neuropathy spectrum disorder. J Clin Neurosci 2012;19(7):927–33. DOI:10.1016/j.jocn.2011.12.003; Biasini F., Portaro S., Mazzeo A. et al. TRPV4 related scapuloperoneal spinal muscular atrophy: Report of an Italian family and review of the literature. Neuromuscul Disord 2016;26(4–5):312–5. DOI:10.1016/j.nmd.2016.02.010; Landoure G., Sullivan J.M., Johnson J.O. et al. Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family. Neurology 2012;79(2):192–4. DOI:10.1212/WNL.0b013e31825f04b2; Unger S., Lausch E., Stanzial F. et al. Fetal akinesia in metatropic dysplasia: The combined phenotype of chondrodysplasia and neuropathy? Am J Med Genet A 2011;155A(11):2860–4. DOI:10.1002/ajmg.a.34268; Faye E., Modaff P., Pauli R. et al. Combined phenotypes of spondylometaphyseal dysplasia–Kozlowski type and Charcot–Marie– Tooth disease type 2C secondary to a TRPV4 pathogenic variant. Mol Syndromol 2019;10(3):154–60. DOI:10.1159/000495778; Муртазина А.Ф., Щагина О.А., Никитин С.С. и др. Современные клинико-генетические представления об аутосомно-рецессивных наследственных периферических нейропатиях. Анналы клинической и экспериментальной неврологии 2019;13(1):55–69. DOI:10.25692/ACEN.2019.1.7; https://nmb.abvpress.ru/jour/article/view/542